Levothyroxine Syri

Levothyroxine Sodium, the active ingredient in Levothyroxine Syri, is a thyroid hormone replacement presented as an oral tablet for oral use. It restores normal metabolic activity by replacing deficient thyroid hormone and is used to treat hypothyroidism and related thyroid disorders in adults and children.

GNH USA supplies Levothyroxine Syri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance and regulatory compliance across multiple markets. Our distribution network covers Europe, Asia, Africa and the Americas, providing reliable access to essential thyroid therapy.

Levothyroxine Syri acts on thyroid hormone pathways to replace deficient thyroxine (T4) in several clinical conditions.

- Hypothyroidism: restores normal thyroid hormone levels, relieving fatigue, weight gain, cold intolerance and metabolic slowdown. - Goiter: reduces thyroid gland enlargement by normalizing circulating hormone levels, helping prevent further growth. - Thyroid cancer suppression: provides hormone replacement after thyroidectomy to suppress TSH stimulation of residual cancer cells, supporting long‑term disease control.

Levothyroxine Syri may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate headache reported in some patients. - Insomnia: difficulty sleeping, especially after dose adjustment. - Palpitations: sensation of rapid or irregular heartbeat. - Heat intolerance: increased sweating and feeling unusually warm. - Tremor: fine shaking of hands or limbs. - Weight loss: unintended loss of body weight.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat requiring emergency care. - Chest pain: possible indication of cardiac ischemia. - Severe tachycardia: markedly elevated heart rate that may need medical attention. - Atrial fibrillation: irregular heart rhythm especially in older patients. - Bone loss: accelerated osteoporosis with long‑term overtreatment. - Anaphylactic reaction: rare severe allergic response.

Before prescribing Levothyroxine Syri, clinicians should consider several precautionary measures to ensure safe use.

- Dose adjustment: required in elderly patients or those with cardiovascular disease. - Monitor thyroid function: regular TSH testing to maintain target hormone levels. - Avoid use in untreated adrenal insufficiency: may precipitate adrenal crisis. - Caution in pregnancy: risk‑benefit assessment needed; therapy often continued. - Review drug interactions: assess concomitant medications that may affect absorption or metabolism. - Store at room temperature: keep in the original container, protect from moisture and light.

Levothyroxine Syri can interact with various medicines, influencing its absorption or hormonal activity.

Major Interactions (Avoid): - Amiodarone: may cause excessive thyroid hormone levels, increasing risk of toxicity. - Antacids containing aluminum or magnesium: reduce levothyroxine absorption if taken simultaneously. - Warfarin: levothyroxine may alter anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of excess thyroid hormone, necessitating careful clinical observation. - Corticosteroids: can increase metabolism of levothyroxine, potentially lowering its efficacy. - Estrogen therapy: may raise levothyroxine dose requirement due to increased binding protein levels.